Atıf Formatları
Personalized therapy for X-linked agammaglobulinemia (XLA) by oligonucleotide-induced splice-correction
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. Bestas Et Al. , "Personalized therapy for X-linked agammaglobulinemia (XLA) by oligonucleotide-induced splice-correction," ESGCT and NVGCT Collaborative Congress , The Hague, Netherlands, 2014

Bestas, B. Et Al. 2014. Personalized therapy for X-linked agammaglobulinemia (XLA) by oligonucleotide-induced splice-correction. ESGCT and NVGCT Collaborative Congress , (The Hague, Netherlands).

Bestas, B., Moreno, P. M. D., Blomberg, K. E. M., Mohammad, D. K., Saleh, A. F., Sutlu, T., ... Nordin, J. Z.(2014). Personalized therapy for X-linked agammaglobulinemia (XLA) by oligonucleotide-induced splice-correction . ESGCT and NVGCT Collaborative Congress, The Hague, Netherlands

Bestas, Burcu Et Al. "Personalized therapy for X-linked agammaglobulinemia (XLA) by oligonucleotide-induced splice-correction," ESGCT and NVGCT Collaborative Congress, The Hague, Netherlands, 2014

Bestas, Burcu Et Al. "Personalized therapy for X-linked agammaglobulinemia (XLA) by oligonucleotide-induced splice-correction." ESGCT and NVGCT Collaborative Congress , The Hague, Netherlands, 2014

Bestas, B. Et Al. (2014) . "Personalized therapy for X-linked agammaglobulinemia (XLA) by oligonucleotide-induced splice-correction." ESGCT and NVGCT Collaborative Congress , The Hague, Netherlands.

@conferencepaper{conferencepaper, author={Burcu Bestas Et Al. }, title={Personalized therapy for X-linked agammaglobulinemia (XLA) by oligonucleotide-induced splice-correction}, congress name={ESGCT and NVGCT Collaborative Congress}, city={The Hague}, country={Netherlands}, year={2014}}